Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

ScanSource Reaffirms Its FY25 Guidance: Sees Net Sales Of $3.1B–$3.5B Vs. $3.439B Est.; Adjusted EBITDA Of $140M–$160M, And Free Cash Flow Of At Least $70M

Author: Benzinga Newsdesk | January 30, 2025 08:45am

Annual Financial Outlook for Fiscal Year 2025

ScanSource reaffirms previously provided guidance set forth below for the full fiscal year ended June 30, 2025.

  FY25 Annual Outlook 
Net sales $3.1 billion to $3.5 billion 
Adjusted EBITDA (non-GAAP) $140 million to $160 million 
Free cash flow (non-GAAP) At least $70 million 

Posted In: SCSC


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist